About this trial
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .
Eligibility criteria
Qualifiers
Inpatients on the Acute care of the Elderly ward.
Disqualifiers
Lack of capacity to consent to the study including moderate-severe dementia or delirium
Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
Patient with known allergic reactions to any part material of the device
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Medtronic - MITG
Lead sponsor
Excelar
Collaborator
Cloud DX Inc.
Collaborator
Bridge Health Solutions
Collaborator
Providence Healthcare
Collaborator